Pharmacodynamic Effects of Pioglitazone on High Molecular Weight Adiponectin Concentrations and Insulin Response After Oral Sugar in Equids.

The research article discusses a study that investigated the effects of pioglitazone, a drug that improves insulin sensitivity in humans, on horses and ponies. The researchers mainly evaluated its impact on insulin response after oral sugar intake.

Experiment Methodology

• The study took the form of a prospective pilot study, with the subjects being fifteen adult equids (8 ponies, 7 horses). The researchers were investigating how the oral administration of pioglitazone (2 mg/kg PO q 24 hours, for 28 days) might affect various parameters.
• These parameters included morphometric details, hepatic enzyme function and activity, adipokines, and an enteroinsular response to oral sugar. Hepatic enzymes refer to proteins in the liver that speed up certain chemical reactions, while adipokines are proteins that are secreted by fat cells and can influence the body’s response to insulin.
• Oral sugar tests (OST) were carried out before and after the pioglitazone treatment, and adipokines were measured on the first day, 14th day, and the 28th day of administration. The researchers also measured plasma drug concentrations on the 14th and 28th day.
• The animals were split into three groups: horses, ponies, and insulin dysregulated (ID) animals. The team compared the baseline values for all parameters with the values obtained on the 14th and 28th day using one-way or two-way analysis of variance.

Findings of the Study

• The study found minor alterations in morphometric parameters and hepatic enzymes. No differences were found in leptin concentrations – leptin being a hormone that helps to regulate energy balance – or in the blood glucose response to the OST.
• However, there was a significant decrease in the insulin response to OST at both the 90-minute and 120-minute time points and the area under the curve. This was the case after pioglitazone treatment in the pony and ID groups.
• The concentrations of high-molecular-weight (HMW) adiponectin were significantly increased in all groups after the pioglitazone treatment. HMW adiponectin is a form of adiponectin that is larger in size and plays an important role in insulin sensitivity and glucose homeostasis.

Significance of the Research

• The reduction in insulin response to oral sugar and the increase in HMW adiponectin concentrations suggest that pioglitazone could have positive effects if used for the treatment of metabolic issues in equine metabolic syndrome.
• These findings highlight the need for further clinical studies on the subject. Pioglitazone, therefore, could potentially have applications in the management of insulin-related issues in equids.